PacBio Earning Call

The PacBio earning call came out, and they did slightly better than expected. However, expectations were not high.

The biggest sign of hope for me was the Vega. This quarter they sold 38, up 10 from Q1. Elsewhere instruments appear to be selling poorly, I assume due to a lack of research funding, and some hesitance that the global system of trade will st…